Structure Therapeutics Extends Financing, Advances Diabetes And Obesity Clinical Program And Changes Name From Shouti
Round Type
Funding Round
Description
Structure Therapeutics Inc. (Structure Therapeutics), formerly known as ShouTi Inc., today announced it closed an oversubscribed $33 million financing round, extending its $100 million Series B financing, which was announced in October 2021. In addition, Structure Therapeutics has completed dosing in a single ascending dose (SAD) Phase 1 study of its lead type 2 diabetes and obesity program, GSBR-1290.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as Structure Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- SpringWorks raised $225M (Post-IPO Equity) on September 7, 2022.
- Abivax raised $49M (Funding Round) on September 2, 2022.
- LumaBridge raised an undisclosed amount (Private Equity) on August 23, 2022.
- MIRA Pharmaceuticals raised $625K (Seed) on July 22, 2022.
- Gossamer Bio raised $120M on July 15, 2022.
- Entero Therapeutics raised $300K (Seed) on July 15, 2022.
Who to call at Structure Therapeutics, and when
A new round usually means Structure Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Structure Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Structure Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Structure Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Structure Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Structure Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.